Microfluidic‐Assisted Metal‐Polyphenol Cloaked Bacteria Enable CRISPR/dCas9‐Mediated Pyroptosis Cascade Amplification for Effective Tumor Immunotherapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202504837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Jingjing Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Pharmacology and Safety Research of Chinese Materia, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, …. Hauptthemen laut MEDLINE: Pyroptosis, Immunotherapy, CRISPR-Cas Systems, Polyphenols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Yangtze River Delta Joint Sci-Tech Innovation and Research Projects, Supporting the Innovation Projects of State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, project of Nanjing University of Chinese Medicine to NSFC.
Abstract (Originalsprache)
Pyroptosis triggered by pore‐forming Gasdermin proteins in cancer cells facilitates anti‐tumor immune activation by releasing pro‐inflammatory cytokines and immunogenic contents following cellular rupture. However, selectively triggering pyroptosis in tumors still remain limited in clinical applications. Here, it is reported a microfluidic‐assisted bacterial delivery system using attenuated Salmonella typhimurium VNP20009 encapsulated with metal‐phenolic networks composed of ferric ions (Fe 3 + ) and tannic acid (TA) to enhance intracellular gasdermin D (GSDMD) expression through targeted CRISPR/dCas9 delivery, thereby inducing robust tumor pyroptosis. Mechanistically, this system achieves cascade amplification of pyroptotic cell death through coordinated multi‐modal mechanisms. Following systemic administration, VNP20009 specifically accumulates in hypoxic tumor regions while the coated Fe 3 + –TA nanofilm undergoes pH‐responsive dissolution in the acidic tumor microenvironment (TME), simultaneously generating ROS through Fenton reaction and releasing CRISPR/dCas9 system to upregulate GSDMD expression. Concurrently, the abundant flagella of VNP activate caspase‐1, which in turn cleaves the overexpressed GSDMD proteins into its active form, thereby triggering robust pyroptosis in tumor cells. Taken together, by coupling bacterial adjuvanticity with ROS‐mediated stress and CRISPR‐driven GSDMD upregulation, this strategy achieves efficient amplification of pyroptosis and promotes antitumor immune activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for Pharmacology and Safety Research of Chinese Materia, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Xin Han
Förderung
- Yangtze River Delta Joint Sci-Tech Innovation and Research Projects
- Supporting the Innovation Projects of State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture
- project of Nanjing University of Chinese Medicine to NSFC
- Jiangsu Key Discipline Construction Fund of the 14th Five-Year Plan (Biology)
- National Natural Science Foundation of China
Zitieren
APA
Yang, J., Yang, J., Liu, K., Wang, S., Hu, Y., Li, J., Wang, H., Jiang, D., & Han, X. (2026). Microfluidic‐Assisted Metal‐Polyphenol Cloaked Bacteria Enable CRISPR/dCas9‐Mediated Pyroptosis Cascade Amplification for Effective Tumor Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504837
Vancouver
Yang J, Yang J, Liu K, Wang S, Hu Y, Li J, et al. Microfluidic‐Assisted Metal‐Polyphenol Cloaked Bacteria Enable CRISPR/dCas9‐Mediated Pyroptosis Cascade Amplification for Effective Tumor Immunotherapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504837
BibTeX
@article{Yang2026,
author = {Yang, Jingjing and Yang, Jiawei and Liu, Kunguo and Wang, Shijie and Hu, Ye and Li, Juanjuan and Wang, Hao and Jiang, Dan and Han, Xin},
title = {Microfluidic‐Assisted Metal‐Polyphenol Cloaked Bacteria Enable CRISPR/dCas9‐Mediated Pyroptosis Cascade Amplification for Effective Tumor Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202504837}
}
EUVIMED